Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 28, 2015 4:04 AM ET


Company Overview of Neuraltus Pharmaceuticals, Inc.

Executive Profile

Edgar G. Engleman M.D.

AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 13 different industries.

See Board Relationships


Dr. Edgar G. Engleman, M.D. serves as a Managing Partner of Vivo Capital, LLC. Dr. Engleman is a Founding Member and serves as a Managing Member of various portfolios of Biotechnology Development Fund VI, L.P. Dr. Engleman serves as a Managing Partner of Vivo Ventures Fund VI, L.P., Biotechnology Development Fund III, L.P., Biotechnology Development Fund IV, L.P., Biotechnology Development Fund II, L.P and Vivo Ventures Fund VII, L.P. He joined the Vivo in 1997. He co-founded ...

Corporate Headquarters

2479 East Bayshore Road
Palo Alto, California 94303

United States

Phone: 650-424-1600
Fax: 650-320-8504

Board Members Memberships

Independent Director, Member of Nominating & Corporate Governance Committee and Member of Disclosure Committee


Harvard University
Columbia University Medical Center

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neuraltus Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at